Viewing StudyNCT00853827

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 9:17 PM
Last Modification Date: 2024-10-26 @ 10:02 AM
Study NCT ID: NCT00853827
Status: COMPLETED
Last Update Posted: 2014-06-03
First Post: 2009-02-26
Brief Title: Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients
Sponsor: Novartis Pharmaceuticals
Organization: Novartis
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Coronary Atherosclerosis
Coronary Artery Disease CAD
Keywords:
Name View
coronary atheroma View
CAD View
coronary artery disease View
coronary atherosclerosis View
coronary angiography View
IVUS View
intravascular ultrasound View
plasma renin activity View
renin angiotensin aldosterone system View
direct renin inhibitors View